About the Authors
- Simone Buraschi
-
Contributed equally to this work with: Simone Buraschi, Thomas Neill
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Thomas Neill
-
Contributed equally to this work with: Simone Buraschi, Thomas Neill
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Rick T. Owens
-
Affiliation LifeCell Corporation, Branchburg, New Jersey, United States of America
- Leonardo A. Iniguez
-
Affiliation Roche NimbleGen, Inc., Research and Development, Madison, Wisconsin, United States of America
- George Purkins
-
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Rajanikanth Vadigepalli
-
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Barry Evans
-
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Liliana Schaefer
-
Affiliation Department of Pharmacology, Goethe University, Frankfurt, Germany
- Stephen C. Peiper
-
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Zi-Xuan Wang
-
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
- Renato V. Iozzo
-
* E-mail: iozzo@kimmelcancercenter.org
Affiliation Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
Competing Interests
RTO works for LifeCell Co. and has provided the recombinant decorin used for the studies. LAI works for Roche-NibleGen Co. and has provided expertise in performing the microarray data. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RVI SB TN. Performed the experiments: SB TN. Analyzed the data: RVI SB TN GP RV BE LS Z-XW. Contributed reagents/materials/analysis tools: RTO LAI SCP Z-XW. Wrote the paper: RVI SB TN.